Prevalence, clinical profile, and cardiovascular outcomes of atrial fibrillation patients with atherothrombosis

Benjamin, 1998, Impact of atrial fibrillation on the risk of death: the Framingham Heart Study, Circulation, 98, 946, 10.1161/01.CIR.98.10.946 Wachtell, 2005, Cardiovascular morbidity and mortality in hypertensive patients with a history of atrial fibrillation: The Losartan Intervention For End Point Reduction in Hypertension (LIFE) study, J Am Coll Cardiol, 45, 705, 10.1016/j.jacc.2004.06.080 Miyasaka, 2007, Coronary ischemic events after first atrial fibrillation: risk and survival, Am J Med, 120, 357, 10.1016/j.amjmed.2006.06.042 Feinberg, 1995, Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications, Arch Intern Med, 155, 469, 10.1001/archinte.1995.00430050045005 Heeringa, 2006, Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study, Eur Heart J, 27, 949, 10.1093/eurheartj/ehi825 Lloyd-Jones, 2004, Lifetime risk for development of atrial fibrillation: the Framingham Heart Study, Circulation, 110, 1042, 10.1161/01.CIR.0000140263.20897.42 Benjamin, 1994, Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study, JAMA, 271, 840, 10.1001/jama.1994.03510350050036 Frost, 2005, Overweight and obesity as risk factors for atrial fibrillation or flutter: the Danish Diet, Cancer, and Health Study, Am J Med, 118, 489, 10.1016/j.amjmed.2005.01.031 Ostgren, 2004, Atrial fibrillation and its association with type 2 diabetes and hypertension in a Swedish community, Diabetes Obes Metab, 6, 367, 10.1111/j.1462-8902.2004.00358.x Go, 2001, Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study, JAMA, 285, 2370, 10.1001/jama.285.18.2370 Bhatt, 2006, International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis, JAMA, 295, 180, 10.1001/jama.295.2.180 Ohman, 2006, The REduction of Atherothrombosis for Continued Health (REACH) Registry: an international, prospective, observational investigation in subjects at risk for atherothrombotic events—study design, Am Heart J, 151, 786.e1, 10.1016/j.ahj.2005.11.004 Steg, 2007, One-year cardiovascular event rates in outpatients with atherothrombosis, JAMA, 297, 1197, 10.1001/jama.297.11.1197 Laguna, 2005, Differences among clinical classification schemes for predicting stroke in atrial fibrillation: implications for therapy in daily practice, Acad Emerg Med, 12, 828, 10.1197/j.aem.2005.04.018 Gage, 2001, Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation, JAMA, 285, 2864, 10.1001/jama.285.22.2864 Holland, 1987, An improved sequentially rejective Bonferroni test procedure, Biometrics, 43, 417, 10.2307/2531823 Yusuf, 2001, Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation, N Engl J Med, 345, 494, 10.1056/NEJMoa010746 Mehta, 2001, Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study, Lancet, 358, 527, 10.1016/S0140-6736(01)05701-4 Beinart, 2005, Long-term cost effectiveness of early and sustained dual oral antiplatelet therapy with clopidogrel given for up to one year after percutaneous coronary intervention results: from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial, J Am Coll Cardiol, 46, 761, 10.1016/j.jacc.2005.03.073 Laskey, 2007, Thrombosis in coronary drug-eluting stents: report from the meeting of the Circulatory System Medical Devices Advisory Panel of the Food and Drug Administration Center for Devices and Radiologic Health, December 7-8, 2006, Circulation, 115, 2352, 10.1161/CIRCULATIONAHA.107.688416 Connolly, 2006, Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial, Lancet, 367, 1903, 10.1016/S0140-6736(06)68845-4 Wolf, 1987, Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study, Arch Intern Med, 147, 1561, 10.1001/archinte.1987.00370090041008 Tanizaki, 2000, Incidence and risk factors for subtypes of cerebral infarction in a general population: the Hisayama study, Stroke, 31, 2616, 10.1161/01.STR.31.11.2616 Kopecky, 1999, Lone atrial fibrillation in elderly persons: a marker for cardiovascular risk, Arch Intern Med, 159, 1118, 10.1001/archinte.159.10.1118 Hart, 2003, Lessons from the Stroke Prevention in Atrial Fibrillation trials, Ann Intern Med, 138, 831, 10.7326/0003-4819-138-10-200305200-00011 Hart, 2002, Atrial fibrillation, stroke, and acute antithrombotic therapy: analysis of randomized clinical trials, Stroke, 33, 2722, 10.1161/01.STR.0000035735.49388.4A Mant, 2007, Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial, Lancet, 370, 493, 10.1016/S0140-6736(07)61233-1 Fuster, 2006, Circulation, 114, e257, 10.1161/CIRCULATIONAHA.106.177292 Lip, 2006, Stroke prevention with aspirin, warfarin and ximelagatran in patients with non-valvular atrial fibrillation: a systematic review and meta-analysis, Thromb Res, 118, 321, 10.1016/j.thromres.2005.08.007 Sato, 2006, Low-dose aspirin for prevention of stroke in low-risk patients with atrial fibrillation: Japan Atrial Fibrillation Stroke Trial, Stroke, 37, 447, 10.1161/01.STR.0000198839.61112.ee Lakshminarayan, 2006, Atrial fibrillation and stroke in the general Medicare population: a 10-year perspective (1992 to 2002), Stroke, 37, 1969, 10.1161/01.STR.0000230607.07928.17 Testa, 2007, Adjusted indirect meta-analysis of aspirin plus warfarin at international normalized ratios 2 to 3 versus aspirin plus clopidogrel after acute coronary syndromes, Am J Cardiol, 99, 1637, 10.1016/j.amjcard.2007.01.052 DeEugenio, 2007, Risk of major bleeding with concomitant dual antiplatelet therapy after percutaneous coronary intervention in patients receiving long-term warfarin therapy, Pharmacotherapy, 27, 691, 10.1592/phco.27.5.691 Singer, 2004, Antithrombotic therapy in atrial fibrillation: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy, Chest, 126, 429S, 10.1378/chest.126.3_suppl.429S Lorenzoni, 2004, Short-term prevention of thromboembolic complications in patients with atrial fibrillation with aspirin plus clopidogrel: the Clopidogrel-Aspirin Atrial Fibrillation (CLAAF) pilot study, Am Heart J, 148, e6, 10.1016/j.ahj.2004.02.008 Wyse, 2002, A comparison of rate control and rhythm control in patients with atrial fibrillation, N Engl J Med, 347, 1825, 10.1056/NEJMoa021328 Atrial Fibrillation Investigators, 1994, Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials, Arch Intern Med, 154, 1449, 10.1001/archinte.1994.00420130036007